Abstract
Macrophages are important in inflammatory processes in heart disease and in transplantation rejection. A resurgence of interest in the macrophage has emanated from recent evidence implicating it as an effector cell in atherosclerosis and transplantation rejection. The detailed distribution of the macrophage within the normal human heart is unknown. We quantified macrophage numbers in the different chambers of the heart. Large tissue blocks (1.5–2.0 cm3) were removed from specific sites in 5 ‘normal’ control hearts (2 males, 3 females, age range 19–46 y). Paraffin-embedded sections were stained with a CD68 pan macrophage marker. Positive cells were enumerated within 20 random fields. Results were analysed using a generalised linear modelling method using the Poisson distribution. Macrophages were identified within septa, and often close to blood vessels, in the myocardium, and in the majority of areas in all hearts. Macrophage numbers varied significantly between areas (range 0–6 cells/high power field; P<0.001), and between the 5 hearts analysed (P<0.001). In general, there were significantly more macrophages in the ventricles (RV P<0.01, LV P<0.05), but these differences were affected by heart differences. This study provides a baseline for the range of macrophage numbers within normal hearts, thus enabling comparisons with macrophage numbers within diseased and transplanted hearts.
Keywords: Mononuclear phagocytes, myocardium
Full Text
The Full Text of this article is available as a PDF (451.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander D. Z., Pearson T. C., Hendrix R., Ritchie S. C., Larsen C. P. Analysis of effector mechanisms in murine cardiac allograft rejection. Transpl Immunol. 1996 Mar;4(1):46–48. doi: 10.1016/s0966-3274(96)80033-5. [DOI] [PubMed] [Google Scholar]
- Arbustini E., Grasso M., Diegoli M., Bramerio M., Foglieni A. S., Albertario M., Martinelli L., Gavazzi A., Goggi C., Campana C. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. Am J Pathol. 1991 Oct;139(4):709–715. [PMC free article] [PubMed] [Google Scholar]
- Aretz H. T., Billingham M. E., Edwards W. D., Factor S. M., Fallon J. T., Fenoglio J. J., Jr, Olsen E. G., Schoen F. J. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan;1(1):3–14. [PubMed] [Google Scholar]
- Azzawi M., Grant S. D., Hasleton P. S., Yonan N., Campbell C. S., Deiraniya A. K., Rahman A., Hutchinson I. V. TNF alpha mRNA and protein in cardiac transplant biopsies: comparison with serum TNF alpha levels. Cardiovasc Res. 1996 Sep;32(3):551–556. [PubMed] [Google Scholar]
- DUNNILL M. S. EVALUATION OF A SIMPLE METHOD OF SAMPLING THE LUNG FOR QUANTITATIVE HISTOLOGICAL ANALYSIS. Thorax. 1964 Sep;19:443–448. doi: 10.1136/thx.19.5.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Falini B., Flenghi L., Pileri S., Gambacorta M., Bigerna B., Durkop H., Eitelbach F., Thiele J., Pacini R., Cavaliere A. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol. 1993 May;142(5):1359–1372. [PMC free article] [PubMed] [Google Scholar]
- Levine B., Kalman J., Mayer L., Fillit H. M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241. doi: 10.1056/NEJM199007263230405. [DOI] [PubMed] [Google Scholar]
- Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994 Dec;72(6):561–566. doi: 10.1136/hrt.72.6.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maury C. P., Teppo A. M. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med. 1989 May;225(5):333–336. doi: 10.1111/j.1365-2796.1989.tb00090.x. [DOI] [PubMed] [Google Scholar]
- Peters J. H., Gieseler R., Thiele B., Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today. 1996 Jun;17(6):273–278. doi: 10.1016/0167-5699(96)80544-5. [DOI] [PubMed] [Google Scholar]
- Ratliff N. B., McMahon J. T. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants. J Heart Lung Transplant. 1995 Mar-Apr;14(2):338–345. [PubMed] [Google Scholar]
- Spencer S. C., Fabre J. W. Characterization of the tissue macrophage and the interstitial dendritic cell as distinct leukocytes normally resident in the connective tissue of rat heart. J Exp Med. 1990 Jun 1;171(6):1841–1851. doi: 10.1084/jem.171.6.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Torre-Amione G., Kapadia S., Lee J., Durand J. B., Bies R. D., Young J. B., Mann D. L. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996 Feb 15;93(4):704–711. doi: 10.1161/01.cir.93.4.704. [DOI] [PubMed] [Google Scholar]
- Wijngaard P. L., Tuijnman W. B., Gmelig Meyling F. H., van der Meulen A., Huytink M., Jambroes G., Schuurman H. J. Endomyocardial biopsies after heart transplantation. The presence of markers indicative of activation. Transplantation. 1993 Jan;55(1):103–110. doi: 10.1097/00007890-199301000-00020. [DOI] [PubMed] [Google Scholar]
- Wildhirt S. M., Dudek R. R., Suzuki H., Pinto V., Narayan K. S., Bing R. J. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res. 1995 Apr;29(4):526–531. [PubMed] [Google Scholar]
- Ziegler-Heitbrock H. W. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today. 1996 Sep;17(9):424–428. doi: 10.1016/0167-5699(96)10029-3. [DOI] [PubMed] [Google Scholar]
